Gene Therapy for Achromatopsia (CNGA3)
Clinical trial NCT03758404 · COMPLETED
Trial details
- NCT number
- NCT03758404
- Sponsor
- MeiraGTx UK II Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2021-06-10
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.